iNova Pharmaceuticals - GOLD CROSS PRINCARD aspirin 100mg enteric coated tablet bottle

Approval under section 42DG for use of restricted representations by iNova Pharmaceuticals

I, Rowena Love, Delegate of the Secretary to the Department of Health, on receipt of an application by iNova Pharmaceuticals, have approved under section 42DG(2) of the Therapeutic Goods Act 1989 (the Act), the use of the below stated restricted representations described in paragraphs (a) - (d) below for use in advertisements directed to consumers, for the product identified in paragraph (e):

1. Helps prevent blood clotting; and/or
2. Reduces the risk of heart attack and stroke in patients with known cardiovascular disease or cerebrovascular disease; and/or
3. For the treatment of patients with known cardiovascular disease or cerebrovascular disease; and/or
4. Anti-platelet agent.
5. "GOLD CROSS PRINCARD aspirin 100mg enteric coated tablet bottle" (AUST R 178832).

Dated this 23rd day of October 2020

Signed electronically

Rowena Love
Delegate of the Secretary to the Department of Health
Advertising Education and Assurance Section
Regulatory Compliance Branch